CADL - Company ID 0001841387
The table below shows Candel Therapeutics, Inc.'s balance sheet line items across its last 5 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Cash & equivalents | $119.73M | $102.65M | $35.41M | $70.06M | $82.64M |
| Short-term investments | - | - | - | - | - |
| Receivables | - | - | - | - | - |
| Inventory | - | - | - | - | - |
| Total current assets | $121.39M | $103.80M | $36.80M | $71.94M | $84.94M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Property, plant & equipment | $1.64M | $2.19M | $3.21M | $4.42M | $3.84M |
| Goodwill | - | - | - | - | - |
| Total assets | $125.19M | $106.87M | $41.20M | $77.69M | $89.20M |
| Accounts payable | $1.13M | $237.00K | $422.00K | $380.00K | $1.59M |
| Total current liabilities | $9.00M | $37.53M | $14.18M | $5.62M | $5.36M |
| Long-term debt | - | $1.73M | $11.63M | - | $560.00K |
| Total liabilities | $73.27M | $40.54M | $28.46M | $29.98M | $25.07M |
| Retained earnings | -$230.39M | -$192.21M | -$137.03M | -$99.09M | -$80.30M |
| Total equity | $51.92M | $66.33M | $12.74M | $47.71M | $64.14M |